Due to health issues, this site is no longer maintained and will be shut down shortly. |
Athersys Inc is a biopharmaceutical company engaged in the discovery and development of therapeutic product candidates designed to extend and improve the quality of human life.
$1.35 -0.10 (-6.90%)
As of 03/24/2023 16:00:01 EST IEX book CBOE book
2022 © Stock Market MBA, Inc.